- $122.27m
- -$40.55m
- CNY922.20m
- 86
- 91
- 87
- 99
Annual income statement for Ihuman, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 532 | 945 | 986 | 1,018 | 922 |
| Cost of Revenue | |||||
| Gross Profit | 365 | 661 | 691 | 721 | 640 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 576 | 999 | 874 | 858 | 850 |
| Operating Profit | -44.5 | -54.2 | 112 | 160 | 71.9 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -37 | -37.2 | 133 | 203 | 111 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -37.5 | -37.1 | 110 | 181 | 98.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -37.5 | -37.1 | 110 | 181 | 98.6 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -48.3 | -37.1 | 110 | 181 | 98.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.213 | -0.139 | 0.406 | 0.661 | 0.364 |